| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |